Skip to main content
SpringerLink
Log in

Assessing Ovarian Reserve

  • Chapter
  • First Online:
Pediatric and Adolescent Oncofertility

  • 546 Accesses

Abstract

Female cancer survivors are at risk for decreased fertility and early menopause usually due to the impact of therapy on the oocytes and ovaries. The ability to assess ovarian reserve or number of oocytes in the ovaries may significantly improve care by elucidating which therapies and patients are at higher risk of ovarian failure, as well as which patients would benefit most from fertility preservation therapies. Current markers of ovarian reserve were developed and have been well studied in infertile populations; thus, their utility in children and adolescents who undergo cancer therapy remains unknown. This chapter will discuss currently used markers of fertility and ovarian reserve and their implications in girls with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Byrne J, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166(3):788–93.

    Article  CAS  PubMed  Google Scholar 

  2. Green DM, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2374–81.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Thomas-Teinturier C, et al. Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: earlier but rarely premature. Hum Reprod. 2013;28(2):488–95.

    Article  PubMed  Google Scholar 

  4. Zegers-Hochschild F, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009;92(5):1520–4.

    Article  CAS  PubMed  Google Scholar 

  5. Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996;11(7):1484–6.

    Article  CAS  PubMed  Google Scholar 

  6. Practice committee of the american society for reproductive medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015;103(3):e9–17.

    Google Scholar 

  7. Goodwin PJ, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17(8):2365–70.

    CAS  PubMed  Google Scholar 

  8. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718–29.

    CAS  PubMed  Google Scholar 

  9. Koyama H, et al. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer. 1977;39(4):1403–9.

    Article  CAS  PubMed  Google Scholar 

  10. Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: reliability and utility. Curr Opin Obstet Gynecol. 2010;22(4):271–6.

    PubMed  Google Scholar 

  11. ACOG Committee Opinion No. 349, November 2006: menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol. 2006;108(5):1323–8.

    Google Scholar 

  12. Burger HG. The endocrinology of the menopause. Maturitas. 1996;23(2):129–36.

    Article  CAS  PubMed  Google Scholar 

  13. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab. 1987;65(6):1231–7.

    Article  CAS  PubMed  Google Scholar 

  14. Burger HG, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab. 1995;80(12):3537–45.

    CAS  PubMed  Google Scholar 

  15. La Marca A, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113–30.

    Article  PubMed  Google Scholar 

  16. Tsepelidis S, et al. Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod. 2007;22(7):1837–40.

    Article  CAS  PubMed  Google Scholar 

  17. van Rooij IA, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83(4):979–87.

    Article  PubMed  Google Scholar 

  18. Broer SL, et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96(8):2532–9.

    Article  CAS  PubMed  Google Scholar 

  19. Hagen CP, et al. Serum levels of anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab. 2010;95(11):5003–10.

    Article  CAS  PubMed  Google Scholar 

  20. Kelsey TW, et al. A validated model of serum anti-Mullerian hormone from conception to menopause. PLoS One. 2011;6(7):e22024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. van Beek RD, et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin’s lymphoma during childhood. J Clin Endocrinol Metab. 2007;92(10):3869–74.

    Article  PubMed  Google Scholar 

  22. Lie Fong S, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone. Hum Reprod. 2009;24(4):982–90.

    Article  CAS  PubMed  Google Scholar 

  23. Dillon KE, et al. Pretreatment antimullerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertil Steril. 2013;99(2):477–83.

    Article  CAS  PubMed  Google Scholar 

  24. Su HI. Measuring ovarian function in young cancer survivors. Minerva Endocrinol. 2010;35(4):259–70.

    CAS  PubMed  Google Scholar 

  25. Anders C, et al. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest. 2008;26(3):286–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Birch Petersen K, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod. 2015;30(10):2364–75.

    Article  CAS  PubMed  Google Scholar 

  27. Bath LE, et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003;18(11):2368–74.

    Article  CAS  PubMed  Google Scholar 

  28. Larsen EC, et al. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003;88(11):5307–14.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology, Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital of Chicago, 225 E. Chicago Ave Box 30, Chicago, IL, USA

    Yasmin Gosiengfiao MD

  2. Women and Infant Services (MWHC)/Surgery (CNMC), MedStar Washington Hospital Center/Children’s National Medical Center, 110 Irving St NW, Washington, DC, 20010, USA

    Veronica Gomez-Lobo MD

Authors
  1. Yasmin Gosiengfiao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veronica Gomez-Lobo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasmin Gosiengfiao MD .

Editor information

Editors and Affiliations

  1. Obstetrics and Gynecology, Northwestern University, Chicago, Illinois, USA

    Teresa K. Woodruff

  2. Northwestern University, Chicago, Illinois, USA

    Yasmin C. Gosiengfiao

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gosiengfiao, Y., Gomez-Lobo, V. (2017). Assessing Ovarian Reserve. In: Woodruff, T., Gosiengfiao, Y. (eds) Pediatric and Adolescent Oncofertility. Springer, Cham. https://doi.org/10.1007/978-3-319-32973-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32973-4_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32971-0

  • Online ISBN: 978-3-319-32973-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation